Cargando…
Management of chronic rhinosinusitis with nasal polyps in Samter triad by low-dose ASA desensitization or dupilumab
Samter triad is a chronic condition where patients suffer from intolerance to aspirin, recurring nasal polyposis and bronchial asthma. Causative treatment is often hard. Potential approaches are the daily intake of acetylsalicylic acid (ASA), shunting arachidonic acid into the lipoxygenase pathway,...
Autores principales: | Bertlich, Mattis, Ihler, Friedrich, Bertlich, Ines, Weiss, Bernhard G., Gröger, Moritz, Haubner, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500659/ https://www.ncbi.nlm.nih.gov/pubmed/34622875 http://dx.doi.org/10.1097/MD.0000000000027471 |
Ejemplares similares
-
Subgroups in the treatment of nasal polyposis with dupilumab: A retrospective study
por: Bertlich, Mattis, et al.
Publicado: (2022) -
Research progress of glucocorticoid resistance in chronic rhinosinusitis with nasal polyps: A review
por: Chen, Langlang, et al.
Publicado: (2023) -
Simultaneous treatment of Samter triad and prurigo nodularis with dupilumab
por: Bloomstein, Joshua D., et al.
Publicado: (2021) -
Bilateral Inflammatory Aural Polyps: A Manifestation of Samter's Triad
por: Brobst, Robert, et al.
Publicado: (2009) -
Samter’s Triad: State of the Art
por: Kim, Sung-Dong, et al.
Publicado: (2018)